Skip to main content
. 2010 Aug 9;5:437–444. doi: 10.2147/ijn.s10083

Figure 7.

Figure 7

Intracellular accumulation of DNR in K562/A02 cells after treatment with different agent for 48 hours.

Notes: A) control (K562/A02); B) K562/A02 incubated with 1.0 μg/mL DNR; C) K562/A02 incubated with 1.0 μg/mL DNR and 10 μg/mL MNP (Fe3O4); D) K562/A02 incubated with 1.0 μg/mL DNR and PGY1–2; E) K562/A02 incubated with 1.0 μg/mL DNR, 10 μg/mL MNP (Fe3O4) and PGY1–2.

Abbreviations: MNP (Fe3O4), magnetic nanoparticles of Fe3O4; DNR, daunorubicin.